1. Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg 2007;59:464-472. PMID:
17901744.
2. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 2008;26:5213-5219. PMID:
18838709.
3. Dominick SA, Madlensky L, Natarajan L, Pierce JP. Risk factors associated with breast cancer-related lymphedema in the WHEL Study. J Cancer Surviv 2013;7:115-123. PMID:
23212606.
4. Rezende LF, Rocha AVR, Gomes CS. Risk factors for breast cancer related lymphedema. J Vasc Bras 2010;9:233-238.
5. Sarri AJ, Moriguchi SM, Dias R, Peres SV, DA Silva ET, Koga KH, et al. Physiotherapeutic stimulation: Early prevention of lymphedema following axillary lymph node dissection for breast cancer treatment. Exp Ther Med 2010;1:147-152. PMID:
23136607.
6. Dalia RM, Martins GR, Barbosa R, de Lima CF, Siqueira CF. Qualitative and quantitative lymphoscintigraphy in the evaluation of lower limbs lymphedema. Braz Arch Biol Technol 2005;48:159-162.
7. Linnitt N. Lymphoedema: recognition, assessment and management. Br J Community Nurs 2005;10:S20-S26. PMID:
15824708.
8. Deltombe T, Jamart J, Recloux S, Legrand C, Vandenbroeck N, Theys S, et al. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology 2007;40:26-34. PMID:
17539462.
9. Soo JK, Bicanic TA, Heenan S, Mortimer PS. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br J Dermatol 2008;158:1350-1353. PMID:
18241266.
10. Bernas MJ, Askew RL, Armer JM, Cormier JN. Lymphedema: how do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment? Curr Breast Cancer Rep 2010;2:53-58.
11. Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg 2010;145:1055-1063. PMID:
21079093.
12. Ahmed RL, Schmitz KH, Prizment AE, Folsom AR. Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study. Breast Cancer Res Treat 2011;130:981-991. PMID:
21761159.
13. Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 2010;19:2734-2746. PMID:
20978176.
14. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med 2003;44:43-57. PMID:
12515876.
15. Yuan Z, Chen L, Luo Q, Zhu J, Lu H, Zhu R. The role of radionuclide lymphoscintigraphy in extremity lymphedema. Ann Nucl Med 2006;20:341-344. PMID:
16878705.
16. Sadeghi R, Kazemzadeh G, Keshtgar M. Diagnostic application of lymphoscintigraphy in the management of lymphoedema. Hell J Nucl Med 2010;13:6-10. PMID:
20411162.
17. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013;46:1-11. PMID:
23930436.
18. Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med 1998;3:145-156. PMID:
9796078.
19. Ter SE, Alavi A, Kim CK, Merli G. Lymphoscintigraphy: a reliable test for the diagnosis of lymphedema. Clin Nucl Med 1993;18:646-654. PMID:
8403693.
20. Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 1988;167:729-735. PMID:
3363131.
21. Starritt EC, Joseph D, McKinnon JG, Lo SK, de Wilt JH, Thompson JF. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg 2004;240:866-874. PMID:
15492570.
22. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 2008;26:3536-3542. PMID:
18640935.
23. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013;14:500-515. PMID:
23540561.
24. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 2009;16:1959-1972. PMID:
19365624.
25. Chandra RA, Miller CL, Skolny MN, Warren LE, Horick N, Jammallo LS, et al. Radiation therapy risk factors for development of lymphedema in patients treated with regional lymph node irradiation for breast cancer. Int J Radiat Oncol Biol Phys 2015;91:760-764. PMID:
25752389.
26. McLaughlin SA. Lymphedema: separating fact from fiction. Oncology (Williston Park) 2012;26:242-249. PMID:
22545305.
27. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001;92:1783-1787. PMID:
11745250.
28. Kiel KD, Rademacker AW. Early-stage breast cancer: arm edema after wide excision and breast irradiation. Radiology 1996;198:279-283. PMID:
8539394.
29. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007;16:775-782. PMID:
17416770.
30. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72. PMID:
14706589.
31. Hinrichs CS, Watroba NL, Rezaishiraz H, Giese W, Hurd T, Fassl KA, et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol 2004;11:573-580. PMID:
15172932.
32. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009;27:2007-2014. PMID:
19289624.
33. Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol 2009;16:979-988. PMID:
19194754.
34. Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, et al. Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat 2009;113:383-391. PMID:
18297429.
35. Wang L, Li HP, Liu AN, Wang DB, Yang YJ, Duan YQ, et al. A scoring system to predict arm lymphedema risk for individual Chinese breast cancer patients. Breast Care (Basel) 2016;11:52-56. PMID:
27051397.
36. Carena M, Campini R, Zelaschi G, Rossi G, Aprile C, Paroni G. Quantitative lymphoscintigraphy. Eur J Nucl Med 1988;14:88-92. PMID:
3391216.
37. Toyserkani NM, Hvidsten S, Tabatabaeifar S, Simonsen JA, Hoilund-Carlsen PF, Sorensen JA. Tc-99m-human serum albumin transit time as a measure of arm breast cancer-related lymphedema. Plast Reconstr Surg Glob Open 2017;5:e1362. PMID:
28740776.
38. Simonsen J, Hvidsten S, Hoilund-Carlsen PF, Sorensen J, Toyserkani N. Quantification of breast cancer-related lymphedema of the upper limbs. J Nucl Med 2017;58(Suppl 1): 468.
39. Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, et al. Advances in imaging of lymph flow disorders. Radiographics 2000;20:1697-1719. PMID:
11112825.